Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX 04:02:28 2024-05-24 pm EDT 5-day change 1st Jan Change
28.88 USD +0.68% Intraday chart for Pfizer, Inc. +0.56% +0.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... Our Logo
Pfizer: initiative against antibiotic resistance in Malawi CF
The market is good to go until Nvidia’s next quarterly results Our Logo
News Highlights : Top Company News of the Day - Thursday at 9 AM ET DJ
BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi MT
Asymchem Laboratories Buys Pfizer's Former UK Site; Hong Kong Shares Slide 3% MT
News Highlights : Top Company News of the Day - Thursday at 3 AM ET DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET DJ
Health Care Up as Vaccine Makers Gain - Health Care Roundup DJ
US IS IN 'ACTIVE CONVERSATIONS' WITH MRNA VACCINE MAKERS PFIZER… RE
Sector Update: Health Care Stocks Slightly Higher Late Afternoon MT
Sector Update: Health Care MT
Pfizer to Cut Costs in Multi-Year Effort -- Update DJ
Pfizer Looks for $1.5 Billion in Savings by 2027, Expects One-Time Cost Reduction Charge of $1.7 Billion MT
Pfizer to Cut Costs in Multi-Year Effort DJ
Pfizer targets $1.5 bln in savings by 2027 as it streamlines operations RE
Pfizer launches multi-year cost-cuts program, eyes $1.5 bln in savings RE
Pfizer: RSV vaccine launched in Canada CF
Sector Update: Health Care Stocks Advance Late Afternoon MT
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK DJ
Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon MT
Sector Update: Health Care MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.69 USD
Average target price
31.94 USD
Spread / Average Target
+11.32%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period